RN7SL181P

Across TCGA pan-cancer cohorts, RN7SL181P RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RN7SL181P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL181P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL181P is over-expressed in tumor, although a few such as LUAD and BRCA show the opposite, repressed pattern.

LUAD, BRCA, and LIHC are the cancer types where RN7SL181P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL181P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	−0.689	<.001	7	view →
BRCA	All	III,IV	−0.540	<.001	6	view →
LIHC	Female	III,IV	+0.447	.006	5	view →
KIRC	Male	II,III,IV	−0.396	.002	5	view →
THCA	Female	II,III,IV	−0.597	.021	3	view →
CHOL	All	All	+0.650	.010	2	view →
LUSC	All	All	−0.317	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RN7SL181P–LUAD

Open the LUAD breakdown →